tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

AQST Stock Latest News

Aquestive Therapeutics Updates on Strategic Goals and Drug Progress
Company AnnouncementsAquestive Therapeutics Updates on Strategic Goals and Drug Progress
7d ago
8K
AQST
Aquestive Therapeutics provides business update
PremiumThe Fly
Aquestive Therapeutics provides business update
7d ago
AQST
Aquestive Therapeutics receives FDA ODE for Libervant Buccal Film
PremiumThe Fly
Aquestive Therapeutics receives FDA ODE for Libervant Buccal Film
1M ago
AQST
Aquestive Therapeutics initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Aquestive Therapeutics initiated with an Overweight at Cantor Fitzgerald
1M ago
AQST
Aquestive Therapeutics Gains FDA Support for Anaphylm
PremiumCompany Announcements
Aquestive Therapeutics Gains FDA Support for Anaphylm
2M ago
8K
AQST
Aquestive Therapeutics gets positive FDA feedback, affirms NDA submission guide
PremiumThe FlyAquestive Therapeutics gets positive FDA feedback, affirms NDA submission guide
2M ago
AQST
Aquestive Therapeutics Announces Board and Committee Changes
Premium
Company Announcements
Aquestive Therapeutics Announces Board and Committee Changes
2M ago
8K
AQST
Aquestive Therapeutics Advances Drug Candidates Amid Challenges
Premium
Company Announcements
Aquestive Therapeutics Advances Drug Candidates Amid Challenges
2M ago
8K
AQST
Aquestive Therapeutics: Progress in Drug Innovation
PremiumCompany Announcements
Aquestive Therapeutics: Progress in Drug Innovation
3M ago
AQST
Aquestive Therapeutics reports Q3 EPS (13c), consensus (13c)
PremiumThe Fly
Aquestive Therapeutics reports Q3 EPS (13c), consensus (13c)
3M ago
AQST
Aquestive Therapeutics sees FY24 revenue $57M-$60M, consensus $58.01M
PremiumThe Fly
Aquestive Therapeutics sees FY24 revenue $57M-$60M, consensus $58.01M
3M ago
AQST
Aquestive Therapeutics Optimistic Financial and Strategic Outlook
PremiumCompany Announcements
Aquestive Therapeutics Optimistic Financial and Strategic Outlook
3M ago
8K
AQST
Aquestive Therapeutics, Inc. (AQST) Q3 Earnings Cheat Sheet
PremiumPre-EarningsAquestive Therapeutics, Inc. (AQST) Q3 Earnings Cheat Sheet
3M ago
AQST
Aquestive to present subsequent analysis of data from Anaphylm study
Premium
The Fly
Aquestive to present subsequent analysis of data from Anaphylm study
3M ago
AQST
Aquestive announces primary, secondary endpoints met in OAS challenge study
Premium
The Fly
Aquestive announces primary, secondary endpoints met in OAS challenge study
3M ago
AQST
Aquestive Therapeutics’ Breakthrough in Allergy Treatment Study
PremiumCompany Announcements
Aquestive Therapeutics’ Breakthrough in Allergy Treatment Study
3M ago
8K
AQST
Aquestive Therapeutics price target raised to $10 from $9 at H.C. Wainwright
PremiumThe Fly
Aquestive Therapeutics price target raised to $10 from $9 at H.C. Wainwright
4M ago
AQST
Aquestive Therapeutics Showcases Innovations and Market Strategy
PremiumCompany Announcements
Aquestive Therapeutics Showcases Innovations and Market Strategy
4M ago
8K
AQST
Aquestive Therapeutics spotlights epinephrine delivery pipeline at Investor Day
PremiumThe Fly
Aquestive Therapeutics spotlights epinephrine delivery pipeline at Investor Day
4M ago
AQST
Aquestive Therapeutics Outlines Growth and Product Progress
PremiumCompany AnnouncementsAquestive Therapeutics Outlines Growth and Product Progress
4M ago
8K
AQST
Aquestive Therapeutics reiterates expected timing for NDA filing of Anaphylm
Premium
The Fly
Aquestive Therapeutics reiterates expected timing for NDA filing of Anaphylm
5M ago
AQST
Aquestive Therapeutics price target raised to $15 from $13 at Oppenheimer
Premium
The Fly
Aquestive Therapeutics price target raised to $15 from $13 at Oppenheimer
5M ago
AQST
SPRY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >